Clinical study of molecular hydrogen`s effects on cholesterol metabolism

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-14005548

Enrollment

Unknown

Registered

2014-08-27

Start date

2013-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypercholesterolemia and metabolic syndrome

Interventions

Placebo Group:Drinking placebo water or breathing N2 and O2

Hydrogen Group:Drinking hydrogen water or breathing H2 and O2

Eligibility

Sex/Gender

All

Age

45 Years to 60 Years

Inclusion criteria

Inclusion criteria: Total choleterol more than at least 5.18mmol/L and/or Low density lipoprotein-cholesterol more than at least 2.59mmol/L

Exclusion criteria

Exclusion criteria: We excluded patients with any acute and chronic in?ammatory processes, stage 2 or 3 hypertension, unstable coronary artery disease, myocardial infarction or stroke within 6 months preceding the study, symptomatic congestive heart failure, diabetes, autoimmune disorders, thyroid diseases, chronic pancreatitis, impaired renal or hepatic function, nephrotic syndrome and with body mass index above 35 kg/m2.

Design outcomes

Primary

Measure	Time frame
Plasma total cholesterol;plasma low-density lipoprotein cholesterol;plasma high-density lipoprotein cholesterol;triglyceride;malondialdehyde;SOD activity;tumor necrosis factor-alpha;interleukin-6;HDL function;pre-beta-HDL level;	—

Secondary

Measure	Time frame
Plasma glucose levels;	—

Countries

China

Contacts

Public ContactShucun Qin

shucunqin@hotmail.com+86 13583815481

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026